Applied DNA Sciences Files 8-K on Financials

Ticker: BNBX · Form: 8-K · Filed: May 15, 2025 · CIK: 744452

Sentiment: neutral

Topics: financial-reporting, 8-K

Related Tickers: APDN

TL;DR

APDN filed an 8-K on May 15th detailing financial results.

AI Summary

Applied DNA Sciences, Inc. filed an 8-K on May 15, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing details the company's financial performance and related disclosures.

Why It Matters

This filing provides investors with crucial updates on Applied DNA Sciences' financial health and operational results, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial disclosure filing and does not inherently present new risks.

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K?

The 8-K reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.

When was this 8-K filing submitted?

The filing was submitted on May 15, 2025.

What is the primary purpose of this 8-K filing for Applied DNA Sciences?

The primary purpose is to report on the company's results of operations and financial condition.

Where is Applied DNA Sciences, Inc. incorporated?

Applied DNA Sciences, Inc. is incorporated in Delaware.

What is the business address of Applied DNA Sciences, Inc.?

The business address is 50 Health Sciences Drive, Stony Brook, New York.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding APPLIED DNA SCIENCES INC (BNBX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing